Royal Bank of Canada’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$126K Buy
8,474
+6,302
+290% +$93.7K ﹤0.01% 5146
2025
Q1
$35K Sell
2,172
-1,850
-46% -$29.8K ﹤0.01% 5327
2024
Q4
$94K Buy
4,022
+236
+6% +$5.52K ﹤0.01% 4915
2024
Q3
$111K Buy
3,786
+530
+16% +$15.5K ﹤0.01% 4827
2024
Q2
$77K Buy
3,256
+3,200
+5,714% +$75.7K ﹤0.01% 5045
2024
Q1
$2K Buy
+56
New +$2K ﹤0.01% 6252
2023
Q4
Sell
-437
Closed -$5K 6941
2023
Q3
$5K Buy
437
+384
+725% +$4.39K ﹤0.01% 6123
2023
Q2
$1K Buy
+53
New +$1K ﹤0.01% 6619
2022
Q4
Sell
-56
Closed -$1K 7140
2022
Q3
$1K Buy
56
+29
+107% +$518 ﹤0.01% 6777
2022
Q2
$0 Sell
27
-72
-73% ﹤0.01% 7126
2022
Q1
$6K Sell
99
-227
-70% -$13.8K ﹤0.01% 6708
2021
Q4
$39K Buy
326
+107
+49% +$12.8K ﹤0.01% 5980
2021
Q3
$44K Buy
219
+100
+84% +$20.1K ﹤0.01% 5717
2021
Q2
$20K Sell
119
-39
-25% -$6.56K ﹤0.01% 6064
2021
Q1
$32K Buy
158
+83
+111% +$16.8K ﹤0.01% 5669
2020
Q4
$15K Buy
75
+67
+838% +$13.4K ﹤0.01% 5652
2020
Q3
$1K Sell
8
-2
-20% -$250 ﹤0.01% 5982
2020
Q2
$2K Sell
10
-3
-23% -$600 ﹤0.01% 5830
2020
Q1
$2K Sell
13
-78
-86% -$12K ﹤0.01% 5827
2019
Q4
$18K Buy
91
+83
+1,038% +$16.4K ﹤0.01% 5309
2019
Q3
$2K Sell
8
-6
-43% -$1.5K ﹤0.01% 5642
2019
Q2
$2K Buy
14
+6
+75% +$857 ﹤0.01% 5642
2019
Q1
$2K Hold
8
﹤0.01% 5524
2018
Q4
$1K Sell
8
-207
-96% -$25.9K ﹤0.01% 5690
2018
Q3
$52K Sell
215
-254
-54% -$61.4K ﹤0.01% 4622
2018
Q2
$124K Buy
469
+461
+5,763% +$122K ﹤0.01% 4122
2018
Q1
$2K Buy
+8
New +$2K ﹤0.01% 5512
2017
Q4
Hold
0
6016
2017
Q3
Hold
0
6107